P

Pacific Arthritis Care Center | Los Angeles, CA

Research site

(Unclaimed)

Location

5230 Concourse Drive 100, Los Angeles, California, United States of America

Site insights

Top conditions

Top treatments

GLPG1690

Naproxen

MK-7240

Celecoxib

MT-7117

Lenabasum

MK-7240-007

Fasinumab

Tanezumab

HZN-825

0

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 16 total trials

A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis

This is a randomized, double-blind, placebo-controlled, repeat-dose, multicenter trial. Participants will be screened within 6 weeks prior to the Bas...

Active, not recruiting

Diffuse Cutaneous Systemic Sclerosis

Sclerosis, Systemic

Drug: Placebo

Drug: HZN-825 QD

Locations recently updated

Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) (MK-7240-007) (ATHENA-SSc-ILD)

The purpose of this study is to assess the safety and efficacy of tulisokibart in participants with SSc-ILD.

Enrolling

Diffuse Cutaneous Systemic Sclerosis

Interstitial Lung Disease

Diagnostic Test: Companion diagnostic ( CDx)

Drug: Tulisokibart

Trial sponsors

G

C

E

P

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms